Related Experiment Video
Updated: Jun 18, 2026
15:43
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
UCP1 ectopically expressed in murine muscle displays native function and mitigates mitochondrial superoxide
Susanne Keipert1, Susanne Klaus, Gerhard Heldmaier
1German Institute of Human Nutrition, Group of Energy Metabolism, 14558 Nuthetal, Germany. susanne.keipert@dife.de
Biochimica Et Biophysica Acta
|December 5, 2009
Summary
Skeletal muscle uncoupling protein 1 (UCP1) expression reduced mitochondrial superoxide production by 76% in mice. This suggests UCP1 is a viable target for treating metabolic and age-related diseases.
Area of Science:
- Biochemistry
- Mitochondrial Physiology
- Metabolic Disease Research
Background:
- Mitochondrial uncoupling in skeletal muscle is a key therapeutic target for obesity, insulin sensitivity, and age-related diseases.
- Ectopic expression of uncoupling protein 1 (UCP1) in mouse models has shown promise for these conditions.
Purpose of the Study:
- To investigate the regulation of UCP1 expressed in mouse skeletal muscle under the human skeletal actin (HSA) promoter.
- To determine the effect of skeletal muscle UCP1 on mitochondrial superoxide production.
Main Methods:
- Transgenic mice expressing UCP1 in skeletal muscle under the HSA promoter were utilized.
- Regulation of UCP1 activity was tested using GDP (inhibitor) and palmitate (activator).
- Mitochondrial superoxide production was measured during the resting state (State 4).
Main Results:
- Skeletal muscle UCP1 demonstrated native behavior, being inhibited by GDP and reactivated by palmitate.
- Transgenic mice exhibited a 76% reduction in mitochondrial superoxide production during State 4.
- GDP administration restored superoxide production to wildtype levels, confirming the uncoupling effect.
Conclusions:
- UCP1 can be functionally expressed and regulated in mouse skeletal muscle.
- Skeletal muscle UCP1 effectively reduces mitochondrial reactive oxygen species (ROS) production.
- Targeting skeletal muscle UCP1 may offer a therapeutic strategy to mitigate age-related processes and metabolic dysfunction.
